Long-term health-related quality of life improvements among patients treated with lurasidone: results from the open-label extension of a switch trial in schizophrenia

BACKGROUND: Long-term improvement of health-related quality of life (HRQoL) in schizophrenia may improve adherence and reduce relapse and rehospitalization. This analysis examines long-term changes in HRQoL among patients with schizophrenia switched to lurasidone from other antipsychotics. METHODS:...

Descripción completa

Detalles Bibliográficos
Autores principales: Awad, George, Ng-Mak, Daisy, Rajagopalan, Krithika, Hsu, Jay, Pikalov, Andrei, Loebel, Antony
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2016
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888300/
https://www.ncbi.nlm.nih.gov/pubmed/27245981
http://dx.doi.org/10.1186/s12888-016-0879-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4888300/
https://www.ncbi.nlm.nih.gov/pubmed/27245981
http://dx.doi.org/10.1186/s12888-016-0879-5

Ejemplares similares